XIAPEX

This brand name is authorized in Estonia, Lithuania, Poland.

Active ingredients

The drug XIAPEX contains one active pharmaceutical ingredient (API):

1	Collagenase UNII 9X7O8V25IT - COLLAGENASE CLOSTRIDIUM HISTOLYTICUM
	Collagenases are proteinases that hydrolyze collagen under physiological conditions. Collagenase clostridium histolyticum is comprised of a mixture of Class I (AUX-I) and Class II (AUX-II) clostridial collagenases in a defined mass ratio. Both collagenases effectively cleave interstitial collagen but at different sites on the molecule; additionally, they prefer different conformations (triple helical versus denatured or cleaved).
	Read more about Collagenase

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
XIAPEX Powder and solvent for solution for injection	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M09AB02		M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AB Enzymes
Discover more medicines within M09AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1518904
LT	Valstybinė vaistų kontrolės tarnyba	1059266
PL	Rejestru Produktów Leczniczych	100250260